{
  "meta": {
    "title": "Hypothalamus_Pituitary",
    "url": "https://brainandscalpel.vercel.app/hypothalamus-pituitary-00e77f6a.html",
    "scrapedAt": "2025-11-30T11:13:06.149Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortisol levels</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Water deprivation test</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">ADH concentration</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Therapeutic trial of low-dose DDAVP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old male with a recent history of traumatic head injury presents with persistent polyuria.<br>Investigations revealed:<br>Serum osmolality: 290 mOsm/kg (280-295)<br>Urine osmolality: 192 mOsm/kg<br>Which one of the following is the best next step to confirm his diagnosis?</span></p>",
      "unique_key": "DT1196005",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196005,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical presentation of polyuria with low urine osmolality suggests<strong> diabetes insipidus. </strong>The most important test to differentiate the cause of polyuria, either diabetes insipidus or polydipsia, is the Water deprivation test.</p>\n<ul>\n<li>Major causes for polyuria in a patient include:\n<ul>\n<li>Primary polydipsia</li>\n<li>Central diabetic insipidus</li>\n<li>Nephrogenic diabetic insipidus</li>\n</ul>\n</li>\n<li>Diabetes insipidus is a syndrome characterised by the excretion of abnormally large volumes of dilute urine. The 24-h urine volume exceeds <strong>40 mL/kg </strong>(polyuria), and the 24-h urine osmolarity is<strong> &lt;280 mosm/L.</strong></li>\n<li>Diabetes insipidus results from either:\n<ul>\n<li>Decreased production of ADH - Central DI (Pituitary DI)</li>\n<li>Decreased action of ADH - nephrogenic DI</li>\n</ul>\n</li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ul>\n<li><strong>Water deprivation test </strong>is the gold standard to differentiate between polydipsia (psychogenic) and diabetic insipidus. Inference:\n<ul>\n<li>Low urine osmolality - Diabetic insipidus</li>\n<li>High urine osmolality - Psychogenic polydipsia</li>\n</ul>\n</li>\n<li><strong>Administration of 2&mu;g desmopressin </strong>can be used to differentiate central and nephrogenic DI:\n<ul>\n<li>Urine osmolality increase (&gt;50%), central DI</li>\n<li>Urine osmolality increases (5%) in nephrogenic DI</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cortisol (Option A): </strong>Cortisol levels are typically assessed when evaluating adrenal gland disorders. Low cortisol levels suggest adrenal insufficiency (such as Addison's disease), while high levels may point to Cushing's syndrome.</p>\n<p><strong>ADH concentration (Option C): </strong>Measuring ADH levels can assist in identifying the cause of polyuria. In patients with a urine volume &gt; 40 mL/kg and urine osmolality &lt; 300 mOsm/kg, an ADH level &gt; 1 pg/mL supports the diagnosis of nephrogenic diabetes insipidus. Conversely, an ADH level &lt; 1 pg/mL suggests either primary polydipsia or central (pituitary) diabetes insipidus, due to insufficient ADH secretion.</p>\n<p><strong>Therapeutic trial of low-dose DDAVP (Option D): </strong>A therapeutic trial of DDAVP is only appropriate if a diagnosis of DI is confirmed (On the water deprivation test) and helps to differentiate between cranial or nephrogenic diabetes insipidus.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918c35ebbfd-3bc4-4750-b527-eb41a09ced8f.png\">",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in the loss of visual field</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Palpitations</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Worsening nystagmus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male with a known history of acromegaly presents for routine 6-monthly follow-up visit. Which one of the following clinical features is an indicator of disease activity?</span></p>",
      "unique_key": "DT1196006",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196006,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>GH hypersecretion resulting in acromegaly is usually the result of a somatotrope adenoma but may rarely be caused by extrapituitary lesions.</p>\n<p>In acromegaly, the indicators of disease activity are:</p>\n<ul>\n<li>Headache</li>\n<li><strong>Progressive deterioration of visual field</strong></li>\n<li>Uncontrolled diabetes</li>\n<li>Increased sweating</li>\n<li>Increasing joint pain</li>\n<li>Uncontrolled hypertension</li>\n</ul>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">This is a likely case of pseudo-hyponatremia</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Treatment with IV normal saline will improve sodium levels</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal sodium excretion is likely to be normal</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Psychiatric drugs are very unlikely to be related to the underlying condition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 66-year-old male was brought to ER following an episode of seizures. His family reports no prior seizure history, but complains of significant weight loss and a 30-year history of smoking. Investigations revealed:<br>Na+ 109 mmol/L (135-145); K+ 4.2 mmol/L (3.5-5.0); Glucose 126 mg/dL;<br>Urea 3.0 mmol/L (3.2-8.1); Urine Sodium: 68 mmol/ L (&uarr;)<br>Given the most likely diagnosis, which of the following statements is most accurate?</span></p>",
      "unique_key": "DT1196020",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196020,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The biochemistry suggests <strong>SIADH</strong>, as suggested by low serum osmolality calculated as [2(Na + K) + urea + glucose], and inappropriately high urine sodium.</li>\n<li>The clinical background of smoking and weight loss points to <strong>small cell lung carcinoma</strong>, which is associated with SIADH as a <strong>paraneoplastic manifestation</strong>.</li>\n<li>Sodium handling by the kidney is not affected in SIADH.</li>\n<li>The hyponatremia in SIADH is dilutional, due to inappropriately elevated ADH causing water retention.</li>\n<li>Sodium excretion may appear normal or even slightly increased in response to volume expansion, but there is no underlying renal defect.</li>\n</ul>\n<p><strong>Schwartz and Barrter criteria for diagnosis of SIADH:</strong></p>\n<ul>\n<li>Decreased plasma osmolality&lt;275mosm/kg</li>\n<li>Urine osmolality &gt;100mosm/kg</li>\n<li><strong>Clinically euvolemic</strong></li>\n<li>Increase ANP, RAAS inhibited</li>\n<li>Urine sodium &gt;40meq/lit</li>\n<li>Normal thyroid, adrenal, renal and cardiac function.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>This is a likely case of pseudo-hyponatremia (Option A): </strong>SIADH is characterised by hypotonic hyponatremia due to dilutional effect. Pseudohyponatremia occurs in the presence of osmotically active solutes like glucose, mannitol, cholesterol, as seen in hyperglycemia, hyperlipidemia, etc.</p>\n<p><strong>Treatment with IV normal saline will improve sodium levels (Option B):</strong> Treatment with IV saline worsens the condition due to further volume expansion. Treatment of choice for symptomatic hyponatremia is 3% hypertonic saline.</p>\n<p><strong>Psychiatric drugs are very unlikely to be related to the underlying condition (Option D): </strong>A wide range of medications, particularly psychotropic agents, have been associated with SIADH. Notably, tricyclic antidepressants, monoamine oxidase inhibitors, and SSRIs are among the psychiatric drugs commonly implicated.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509189f78a241-1525-4515-a5ab-af8692e36ed2.png\">",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Random GH level</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolactin level</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone suppression test</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum IGF-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old male presents with complaints of increased sweating and daily headaches. On examination, the patient has large spade-like hands and coarsened facial features like a large nose, prominent jaw and thick lips. Which of the following is the most appropriate initial screening test to establish the diagnosis?</span></p>",
      "unique_key": "DT1196030",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196030,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient presents with clinical features suggestive of acromegaly, and the most appropriate screening test to evaluate the condition is serum IGF-1.</p>\n<ul>\n<li>Acromegaly results from <strong>hypersecretion of growth hormone</strong> either due to a somatotrope adenoma or extra pituitary lesions.</li>\n<li>More common in males.</li>\n<li>Both growth hormone and IGF-1 levels are increased.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091873557281-8538-4771-a9be-365f6581eed0.png\">\n<p><strong>Investigations: </strong></p>\n<ul>\n<li>Elevated GH levels increase IGF-1 blood levels, and <strong>elevated IGF-1 levels </strong>almost always indicate acromegaly.</li>\n<li>GH has pulsatile release, so random assessment would not be helpful. Because IGF-1 levels are much more stable for the day, they are often a more practical and reliable measure than GH levels. <em>(Option A ruled out.)</em></li>\n<li>The <strong>oral glucose tolerance test </strong>is the confirmatory test <strong>for</strong> Ingestion of 75 g of the sugar glucose lowers blood GH levels less than 0.4 ng/ml in healthy people. In patients with acromegaly, this reduction does not occur.</li>\n<li>Imaging - MRI brain focusing on sellar region with contrast.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240408d7d4bdfa-279b-4c34-a864-b3eb81b85983.jpg\">\n<p><strong>Fig: </strong>Right side shows acromegalic changes; left side shows normal hands and feet</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Prolactin level (Option B):</strong> Prolactin levels are assessed to diagnose a prolactinoma; levels typically &gt;100 &mu;g/L suggest a microprolactinoma and &gt;250 &mu;g/L indicate a macroprolactinoma.</p>\n<p><strong>Dexamethasone suppression test (Option C):</strong> An overnight 1-mg dexamethasone suppression test can be used to identify patients with hypercortisolism.</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes insipidus</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Diuretic use</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Syndrome of inappropriate ADH secretion (SIADH)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 74-year-old man with a long history of COPD presented with fever, productive cough, and altered mental status. On examination, he is drowsy, blood pressure is 135/80 mmHg, and chest auscultation revealed crackles in the right lower lung field. Laboratory findings are as follows:<br>Na 115 mmol/l, K 3.9 mmol/l; Creatinine 0.70 mg/dl<br>Plasma osmolarity 261 mOsmol/kg; Urine osmolality 560 mOsmol/kg<br>Urine sodium 55 mmol/l<br>Thyroid and cortisol levels were normal. Which of the following is the most likely cause of his current condition?</span></p>",
      "unique_key": "DT1196034",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196034,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient has <strong>pneumonia,</strong> which resulted in <strong>SIADH</strong> due to ADH release by inflamed lung tissue or stress-related pathways.</p>\n<ul>\n<li>SIADH is not an uncommon consequence of pneumonia, particularly in patients of this age group. Small-cell bronchial carcinoma is another cause of SIADH.</li>\n<li>Diagnostic criteria for SIADH:\n<ul>\n<li>Low serum Na</li>\n<li>Low serum osmolality (&lt;275 mOsm/kg)</li>\n<li>Urine osmolality &gt;100 mOsm/kg</li>\n<li>High urine Na &gt; 30 mEq/L</li>\n<li><strong>Euvolemia</strong></li>\n<li>Normal renal, adrenal and thyroid function</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Addison's disease (Option A): </strong>Addison's disease or primary adrenal insufficiency is characterised by hyperkalemia, episodes of hypoglycemia and hypotension.</p>\n<p><strong>Diabetes insipidus (Option B): </strong>Diabetes insipidus is characterised by polyuria and hypernatremia along with low urine osmolality.</p>\n<p><strong>Diuretic use (Option C):</strong> Diuretic use is associated with hyponatremia, but there will be accompanying signs of hypovolemia.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of the somatostatin receptor</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of the growth hormone receptor</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of the somatostatin receptor</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of the dopamine D2 receptor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57-year-old man has persistently elevated growth hormone, despite surgical treatment for acromegaly and has now started on lanreotide. What is the mode of action of lanreotide?</span></p>",
      "unique_key": "DT1196035",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Lanreotide is a<strong> long-acting somatostatin analogue</strong> which specifically stimulates somatostatin receptor-2.<em> (Option A ruled out.)</em></li>\n<li><strong>Stimulation of the somatostatin receptor</strong> leads to inhibition of production of a number of hormones including gastrin, cholecystokinin, glucagon, growth hormone, insulin and secretin.</li>\n<li>Somatostatin analogues are used in the medical management of acromegaly, either before surgery or as adjunctive therapy following surgery or radiotherapy in cases where growth hormone levels remain elevated.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Inhibition of the growth hormone receptor (Option B): </strong>Lanreotide does not inhibit growth hormone receptor, but reduces growth hormone release at the pituitary level by binding to somatostatin receptors.</p>\n<p><strong>Stimulation of the dopamine D2 receptor (Option D): </strong>Stimulation of D2 receptors is the mechanism of action of dopamine agonists like bromocriptine and cabergoline. These are used in the treatment of prolactinomas.</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Start dexamethasone</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Give normal saline 0.9%</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Give 3% hypertonic saline</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Start demeclocycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old man with a history of small cell lung carcinoma is brought to the ER with a grand-mal seizure. His wife reports altered sensorium since 2 days. On examination, he is very drowsy, but has no focal neurological deficits. Lab investigation revealed:<br>Na+ 123 mmol/l<br>K+ 4.0 mmol/l<br>Creatinine 0.8 mg/dl<br>He was started on fluid restriction, but had further decline in serum sodium levels and worsening of mental status. Which of the following represents the most appropriate management for him?</span></p>",
      "unique_key": "DT1196037",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient has symptomatic hyponatremia, likely due to SIADH as a paraneoplastic manifestation of small cell lung carcinoma. Treatment of choice for symptomatic hyponatremia is 3% hypertonic saline, and restricting fluid in this case will not help.</p>\n<ul>\n<li>Treatment of acute symptomatic hyponatremia should include <strong>hypertonic 3% saline </strong>(513 mM) to acutely increase plasma Na+ concentration by 1-2 mM/h to a total of 4-6 mM.</li>\n<li>This modest increase is typically sufficient to alleviate severe acute symptoms, after which corrective guidelines for chronic hyponatremia are appropriate.</li>\n</ul>\n<p><strong>Treatment of SIADH: </strong></p>\n<ul>\n<li><strong>Fluid Restriction: </strong>\n<ul>\n<li>First-line treatment for chronic SIADH.</li>\n<li>Restrict intake to 500 mL less than the patient's 24-hour urine output.</li>\n</ul>\n</li>\n<li><strong>Vaptans </strong>(Vasopressin Receptor Antagonists):\n<ul>\n<li>Tolvaptan: A selective V2 receptor antagonist, and the drug of choice for SIADH.</li>\n<li>Conivaptan: A dual V1a and V2 receptor antagonist, given as a loading dose followed by continuous infusion.</li>\n</ul>\n</li>\n<li><strong>Hypertonic Saline (3%)</strong>\n<ul>\n<li>Used in <strong>acute SIADH</strong> with <strong>moderate to severe symptoms</strong>, such as seizures or altered consciousness.</li>\n</ul>\n</li>\n<li><strong>Demeclocycline</strong>\n<ul>\n<li>Acts by inducing a state of <strong>nephrogenic diabetes insipidus</strong>, reducing the kidney's response to ADH.</li>\n<li>Used in <strong>chronic SIADH</strong>, especially when fluid restriction is ineffective.</li>\n<li>But it is not the first-line treatment in symptomatic acute hyponatremia. <em>(Option D ruled out.)</em></li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Start dexamethasone (Option A): </strong>Dexamethasone is known to have no particular role management of hyponatremia in SIADH.</p>\n<p><strong>Give normal saline 0.9% (Option B): </strong>IV normal saline will further worsen hyponatremia, as more dilution occurs and kidneys continue to excrete sodium.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrogenic diabetes insipidus</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary polydipsia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic diuresis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary diabetes insipidus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old woman presents with increased urine output. Her urine output is 3500 ml/day and has basal urine osmolality of 210 mOsm/kg. During a fluid deprivation test, she loses 3 kg and her urine osmolality rises to 350 mOsm/kg. Following subcutaneous desmopressin, there is minimal rise in urine osmolality after 2 hours. Which of the following is the likely diagnosis?</span></p>",
      "unique_key": "DT1196039",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's urine osmolality increased significantly after fluid deprivation, but increased only minimally after DDAVP. This suggests a likely diagnosis of primary polydipsia.</p>\n<p><strong>Polydipsia </strong>is a condition in which one consumes more water, and in turn results in polyuria. Primary polydipsia is of 2 types:</p>\n<ul>\n<li>Psychogenic\n<ul>\n<li>OCD</li>\n<li>Schizophrenia</li>\n</ul>\n</li>\n<li>Dipsogenic\n<ul>\n<li>Infection (TB meningitis)</li>\n<li>Trauma</li>\n<li>Sarcoidosis</li>\n</ul>\n</li>\n<li>Most important test to differentiate between polydipsia and diabetic insipidus is the <strong>water deprivation test.</strong> Inference following the test, if:\n<ul>\n<li>Urine osmolality decreases- Diabetic insipidus</li>\n<li>Urine osmolality increases - Polydipsia</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Nephrogenic diabetes insipidus (Option A), Pituitary diabetes insipidus (Option D): </strong>Diabetes insipidus is suspected when the urine output is &gt; 50 ml/kg per day. Increase in urine osmolality with water deprivation test indicates DI. Further nephrogenic and pituitary DI can be differentiated by administration of subcutaneous DDAVP, which causes an increased urine osmolality &gt; 300 mOsm/kg in pituitary DI.</p>\n<p><strong>Osmotic diuresis (Option C): </strong>In osmotic diuresis, basal urine osmolality is &gt; 300mOsm/kg. This is usually seen with conditions like hyperglycemia, mannitol administration.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202404086dfe4d26-9b02-4fff-b712-f6226faca761.jpg\">",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Free T3</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid ultrasound scan</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid uptake scan</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary magnetic resonance imaging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old married woman presents with complaints of cold intolerance, weakness and constipation for 3 months. She gives a history of hypertension and peptic ulcer disease and is currently on nifedipine, cimetidine and docusate sodium. She also has regular but scanty menstrual cycles and has not conceived yet. Laboratory tests reveal:<br>Free T4: 6.4 pmol/L (Low) (Normal: 10-22 pmol/L)<br>TSH: 1.5 mIU/L (Normal) (Normal: 0.3-5.0 mIU/L)<br>Normal CBC<br>Which of the following is most likely to confirm the underlying cause?</span></p>",
      "unique_key": "DT1196041",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient presents with clinical features of hypothyroidism. Low levels of T4 with normal TSH suggest <strong>secondary hypothyroidism,</strong> which is due to <strong>hypothalamic-pituitary disease</strong>, which can be assessed with MRI scans.</p>\n<ul>\n<li>In patients with <strong>central (secondary) hypothyroidism</strong>, they should be evaluated for pituitary and end organ function as well as the presence of a pituitary tumour.</li>\n<li>The prolactin level should be measured and the pituitary adrenal, gonadal and growth hormone axes assessed.</li>\n<li>TSH may be either <strong>normal or low </strong>in central hypothyroidism</li>\n<li>The presence of a <strong>pituitary tumour </strong>can be determined by imaging the pituitary gland with <strong>MRI</strong> or computed tomography (CT) scan.</li>\n<li><strong>Pituitary MRI</strong> is the investigation of choice to evaluate for possible pituitary or hypothalamic cause.</li>\n<li>Presence of pituitary tumour should also prompt evaluation for other anterior pituitary hormone status.</li>\n<li>Where appropriate, this should be followed by evaluation of the visual fields.</li>\n<li>Treatment of choice for most pituitary adenomas is trans sphenoidal resection, although microprolactinoma may be managed successfully with dopamine agonist therapy.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Free T3 (Option A): </strong>Circulating unbound T3 levels are normal in ~25% of patients with hypothyroidism, reflecting adaptive deiodinase responses to hypothyroidism. T3 measurements are, therefore, not indicated.</p>\n<p><strong>Thyroid ultrasound scan (Option B): </strong>Thyroid ultrasound scans are used to detect structural abnormalities in the thyroid gland, like goitre and do not help to rule out central or primary hypothyroidism.</p>\n<p><strong>Thyroid uptake scan (Option C): </strong>Radioiodine uptake and thyroid scans are performed if the serum TSH level is subnormal to determine if functioning thyroid nodules are present. Functioning or hot nodules are rarely malignant, and fine-needle aspiration (FNA) biopsy is not indicated. These scans are used in the diagnosis of toxic adenoma, thyroiditis, and Graves' disease.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Left atrial myxoma</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Carney complex</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing disease</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatisation disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old man presents with transient left-sided weakness of his arm, which resolved after a few hours. He reports recent unintentional weight gain. On examination, he has spotty skin pigmentation, abdominal striae and cardiac murmur. Echo revealed left atrial mass on echo, and biochemical evaluation showed elevated serum cortisol with suppressed ACTH. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196045",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient has ACTH-independent Cushing syndrome, myxoma, and spotty skin pigmentation, which is a classic of <strong>Carney complex.</strong></p>\n<ul>\n<li>Carney complex (CNC) is an <strong>autosomal-dominant </strong>condition caused by an inactivating mutation of protein kinase A on chromosome 17.</li>\n<li>It is characterised by:\n<ul>\n<li>Spotty skin pigmentation</li>\n<li><strong>Myxomas</strong> - the most common location for cardiac myxoma is the left atrium</li>\n<li>Psammomatous melanotic schwannoma</li>\n<li>Endocrine tumours that involve the adrenals, Sertoli cells, somatotropes, thyroid, and ovary.</li>\n</ul>\n</li>\n<li>Carney complex is diagnosable with the presence of any two above features.</li>\n<li>It is also diagnosable in the presence of one feature and an affected first-degree relative.</li>\n<li><strong>Cushing's syndrome</strong>, the result of primary pigmented nodular adrenal disease (PPNAD), is the most common endocrine manifestation of CNC.</li>\n<li>These patients often have levels of urinary free cortisol that are normal or increased only marginally.</li>\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-diuretic hormone</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Luteinising hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female presents with irregular menstrual cycles and galactorrhoea. Her visual field examination was normal, and investigations revealed elevated serum prolactin level and a 7mm pituitary adenoma on MRI. Which of the following hormones would you expect to be low in this patient?</span></p>",
      "unique_key": "DT1196049",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In cases of microprolactinomas (tumours &lt;10 mm), mass effect is minimal or absent, so hormones like ADH, ACTH, TSH, and growth hormone are typically not affected. <em>(Option A, B, C ruled out)</em></li>\n<li>Pituitary adenoma&gt; 10mm (<strong>macroadenomas) causes pressure effects</strong>, suppressing production of these hormones.</li>\n<li>Hyperprolactinemia suppresses release of gonadotropin-releasing hormone, which leads to reduced production of LH and FSH.</li>\n<li>There may also be a direct effect of prolactin itself on the ovary to disrupt LH and FSH signalling.</li>\n<li>Patients with prolactin-secreting pituitary adenoma will present with a history of amenorrhoea or galactorrhea.</li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatostatin</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy with a height of 155 cm presents with concerns that he has stopped growing. Which hormone is chiefly responsible for epiphyseal fusion and cessation of growth?</span></p>",
      "unique_key": "DT1196050",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196050,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The growth spurt at puberty is brought about by the secretion of androgens in the male and estrogens in the female. However, it is <strong>estrogens</strong> that ultimately terminate growth by causing the epiphyses in the long bones to fuse.</li>\n<li>Thus, estrogens rather than androgens are responsible for skeletal maturation, epiphyseal fusion and cessation of growth in males and females. <em>(Option B ruled out.)</em></li>\n<li>Thus, <strong>aromatisation of testosterone to estrogen</strong> is obligatory for mediating androgen effects on epiphyseal fusion.</li>\n<li>Growth hormone, thyroxine and insulin are involved in linear growth alone and have no significant role in epiphyseal fusion.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Growth hormone (Option A): GH</strong> increases insulin-like growth factor-1 (IGF-1), which enhances linear growth. But has no role in epiphyseal fusion.</p>\n<p><strong>Somatostatin (Option C): </strong>Somatostatin inhibits secretion of growth hormone and does not contribute to epiphyseal closure.</p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates dopamine release by the hypothalamus</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct stimulatory effect on pituitary lactotrophs</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Binds to D2-receptors on pituitary lactotrophs</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Promotes pituitary adenoma growth</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman recently started on metoclopramide for persistent nausea, complains of galactorrhoea, and amenorrhoea. Which of the following best explains the mechanism by which metoclopramide is causing her symptoms?</span></p>",
      "unique_key": "DT1196060",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196060,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Metoclopramide causes galactorrhoea and amenorrhoea by blocking dopamine D2 receptors on pituitary lactotrophs.</p>\n<ul>\n<li>Metoclopramide is a<strong> dopamine antagonist</strong> that binds to D2-receptors on pituitary lactotrophs.</li>\n<li>This stimulates the release of prolactin by the anterior pituitary, thereby resulting in <strong>galactorrhoea</strong>.</li>\n<li>Prolactin <strong>inhibits gonadotropin-releasing hormone</strong> and gonadotropin secretion per se, and hence oligomenorrhoea or amenorrhoea may occur.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918d1682b61-ad7a-4981-873f-2eafb617a911.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Stimulates dopamine release by the hypothalamus (Option A):</strong> Dopamine secreted from the hypothalamus is the most important negative regulator of prolactin production from the pituitary. And metaclopromide does not stimulate dopamine receptors but blocks these receptors.</p>\n<p><strong>Direct stimulatory effect on pituitary lactotrophs (Option B):</strong> Metoclopramide does not directly stimulate lactotrophs. It indirectly causes prolactin release by blocking dopamine receptors.</p>\n<p><strong>Promotes pituitary adenoma growth (Option D):</strong> Prolactin-secreting pituitary adenomas cause hyperprolactinemia. Metaclopromide does not cause pituitary adenoma growth.</p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolactinoma</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Acromegaly</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man presents with headaches, excessive sweating, galactorrhoea, polyuria and polydipsia. Visual field examination revealed bitemporal hemianopia. His blood pressure is 160/110 mmHg, and laboratory investigations showed fasting glucose 150 mg/dl, prolactin 1200 mU/l (<360). What is the most probable diagnosis?</span></p>",
      "unique_key": "DT1196065",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196065,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical findings of high prolactin, galactorrhoea, and mass effect symptoms like bitemporal hemianopia strongly suggest a <strong>macroprolactinoma</strong>.</p>\n<p><strong>Clinical features</strong></p>\n<ul>\n<li>Females: <strong>Galactorrhea</strong>, amenorrhea, infertility</li>\n<li>Males: Loss of libido, impotence</li>\n<li>Decrease bone mineral density and muscle mass</li>\n<li>Mass effects: Headache, visual disturbances<strong> (bitemporal hemianopia)</strong></li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ul>\n<li>Fasting prolactin levels\n<ul>\n<li>Micro prolactinoma &gt;100&mu;g/L</li>\n<li>Macroprolactinoma &gt;250&mu;g/L</li>\n</ul>\n</li>\n<li>MRI with gadolinium contrast</li>\n</ul>\n<p><strong>Treatment</strong>:</p>\n<ul>\n<li>Oral <strong>dopamine agonists </strong>(cabergoline and bromocriptine) are the mainstay of therapy for patients with micro- or macroprolactinomas.</li>\n<li>DOC of dopamine agonist in pregnancy - Bromocriptine</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Diabetes mellitus (Option B): </strong>Although the patient has elevated fasting glucose levels, this does not explain the high levels of prolactinemia, galactorrhea, and visual field defect.</p>\n<p><strong>Acromegaly (Option C):</strong> Acromegaly due to growth hormone-secreting pituitary tumour can cause hyperprolactinemia due to secretion of prolactin. But there will be associated clinical features of acromegaly, like coarsened facies, and elevated IGF-1.</p>\n<p><strong>Cushing's disease (Option D): </strong>Cushing syndrome can result from ACTH-secreting pituitary tumour (ACTH-dependent Cushing syndrome). Typically presents with central adiposity, proximal myopathy, striae, amenorrhea, hirsutism, impaired glucose tolerance, diastolic hypertension, and osteoporosis.</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Proximal tubule</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortical and medullary collecting tubules</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal convoluted tubule</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Thin ascending limb of Henle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman with polyuria was evaluated with diabetes insipidus. Which part of the nephron is most affected in this condition?</span></p>",
      "unique_key": "DT1196070",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196070,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>ADH acts on V2 receptors in the collecting tubules to concentrate urine. In diabetes insipidus, this action is impaired due to deficiency, making the collecting tubules the most affected site.</p>\n<ul>\n<li>Fine-tuning of salt and water balance is achieved in the distal and collecting tubules under the influence of aldosterone and antidiuretic hormone (ADH).</li>\n<li>ADH, however, plays a central role in urinary concentration by increasing the water permeability of the normally impermeable <strong>cortical and medullary collecting tubules.</strong></li>\n<li>In the absence of ADH, little water is reabsorbed in the collecting tubules and dilute urine is excreted, which results in<strong> diabetes insipidus.</strong></li>\n<li>ADH-mediated water reabsorption from the collecting tubules is facilitated via aquaporin 2 channels on the luminal surface.</li>\n<li>Around 15-20% of renal water reabsorption is ADH-mediated.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Proximal tubule (Option A): </strong>Proximal convoluted tubule is involved with the ADH-independent absorption of around 65% water and most of the solutes, like glucose and amino acids.</p>\n<p><strong>Distal convoluted tubule (Option C): </strong>DCT cells are largely water impermeable, and reabsorb sodium and chloride across the apical membrane via electroneutral pathways.</p>\n<p><strong>Thina ascending limb of Henle's loop (Option D): </strong>Though it helps in some reabsorption from the filtrate, it is mainly involved in creating a concentration gradient in the kidney needed for concentrating urine.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary Hypothyroidism</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH-producing adenoma</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypopituitarism</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman presents with weight loss of 6 kg over 6 months, increased fatigue and prostration during febrile episodes. Investigation showed low Free T3, low Free T4 and low TSH. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196073",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196073,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient is likely to be suffering from multiple pituitary hormone deficiencies.</li>\n<li>Low T3 and T4 in the presence of low TSH suggests <strong>central hypothyroidism</strong>. Isolated secondary hypothyroidism would not usually be associated with weight loss.</li>\n<li>Presence of significant weight loss and excessive fatigue during febrile episodes is suggestive of coexistent secondary adrenal insufficiency. Low cortisol and ACTH values would confirm the same.</li>\n<li>The investigation of choice to elucidate the cause is <strong>MRI of the pituitary fossa </strong>to exclude a pituitary tumour.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Primary Hypothyroidism (Option A): </strong>In primary hypothyroidism, laboratory investigations typically show elevated TSH and low T4 levels.</p>\n<p><strong>TSH-producing adenoma (Option B): </strong>Patients usually present with thyroid goitre and hyperthyroidism, reflecting chronic overproduction of TSH. Diagnosis is based on demonstrating elevated serum free T4 levels, inappropriately normal or high TSH secretion, and MRI evidence of a pituitary adenoma.</p>\n<p><strong>Addison's disease (Option D):</strong> Addison's disease refers to primary adrenal insufficiency. Though patient will also presents with fatigue and weight loss, it is associated with slightly increased TSH levels due to loss of feedback inhibition of TSH release.</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Empty sella syndrome</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Nelson's syndrome</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphocytic Hypophysitis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Sheehan's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman, 3 months postpartum, presents with tiredness, amenorrhea since childbirth and inability to breast-feed due to lack of milk production. Her previous record indicates blood transfusion during her previous delivery for postpartum haemorrhage. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196077",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196077,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical presentation suggests a likely diagnosis of Sheehan syndrome.</p>\n<ul>\n<li>Sheehan's syndrome refers to<strong> hypopituitarism</strong> caused by infarction of the pituitary gland following severe postpartum haemorrhage.</li>\n<li>The <strong>haemorrhage </strong>and associated <strong>hypotension </strong>are thought to cause pituitary <strong>infarction</strong>.</li>\n<li>A classic symptom of Sheehan syndrome is the absence of postpartum lactation, which is related to prolactin deficiency.</li>\n<li>Patients fail to lactate and remain amenorrhoeic post-delivery, and also develop other pituitary hormone deficiencies of the thyroid and adrenal axis.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Empty sella syndrome (Option A): </strong>Empty sella syndrome is associated with hypopituitarism; imaging of the pituitary fossa shows no obvious pituitary tissue. It is idiopathic.</p>\n<p><strong>Nelson's syndrome (Option B): </strong>Nelson's syndrome is seen in patients with pituitary-driven Cushing's syndrome many years after bilateral adrenalectomy. Such patients are deeply pigmented.</p>\n<p><strong>Lymphocytic hypophysitis (Option C):</strong> Lymphocytic hypophysitis is an inflammation of the pituitary gland occurring in the 3rd trimester or postpartum females. They tend to present with mass effects and features of anterior pituitary hormone deficiency, commonly ACTH and TSH.</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Low-dose dexamethasone suppression test</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Synacthen test</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">24-hour urinary cortisol collection</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">High-dose dexamethasone suppression test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An obese patient with a history of hypertension and diabetes presents with reddish abdominal striae, palmar hyperpigmentation and has recently suffered a left Colles fracture. On evaluation, midnight cortisol was elevated, and ACTH-dependent Cushing syndrome was suspected. Which test would best confirm a diagnosis of Cushing's disease?</span></p>",
      "unique_key": "DT1196086",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In a patient with features of <strong>ACTH-dependent Cushing's syndrome</strong>, a high-dose dexamethasone suppression test will confirm the diagnosis.</p>\n<ul>\n<li>ACTH-dependent Cushing syndrome may result from either a pituitary <strong>ACTH-secreting adenoma</strong> (Cushing disease) or ectopic ACTH production from non-pituitary tumours.</li>\n<li>These two etiologies can be distinguished using the <strong>high-dose dexamethasone suppression test.</strong><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202404087e34df16-706a-4913-9ed3-b09a9728dae1.jpg\"><br></li>\n<li><strong>Low dose dexamethasone suppression</strong>, overnight dexamethasone suppression tests, <strong>urine free cortisol,</strong> late night salivary and plasma cortisol are used to confirm the diagnosis of Cushing syndrome <em>(Option A, C ruled out).</em></li>\n<li>High levels of ACTH in ACTH-dependent Cushing syndrome are responsible for the hyperpigmentation seen in nailbeds and mucosa.</li>\n<li><strong>Inferior petrosal sinus sampling </strong>is the <strong>gold-standard test</strong> to establish a diagnosis of pituitary-dependent Cushing's syndrome. This sampling is usually done in conjunction with corticotropin-releasing hormone.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Synacthen test (Option B): </strong>Synacthen test is an ACTH stimulation test used to evaluate adrenal insufficiency. It cannot be used to diagnose Cushing syndrome.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p><strong>High dose dexamethasone suppression is used to differentiate between Cushing disease and ectopic ACTH-dependent Cushing.</strong></p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">SIADH</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrogenic diabetes insipidus</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary polydipsia</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Central diabetes insipidus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old boy with diabetes insipidus is currently being treated with desmopressin. Despite therapy, he continues to experience polyuria, polydipsia, and nocturia. Laboratory investigations reveal a fasting blood glucose of 108 mg/dL, sodium 139 mmol/L, potassium 4.5 mmol/L, and calcium 10.9 mg/dL. Which of the following is the most likely explanation for his persistent symptoms?</span></p>",
      "unique_key": "DT1196094",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196094,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The boy remains symptomatic despite desmopressin treatment, which indicates <strong>nephrogenic diabetes insipidus</strong>, where the kidneys are resistant to the action of ADH. Desmopressin is a synthetic analogue of ADH.</p>\n<ul>\n<li>In nephrogenic diabetic insipidus, renal tubules are <strong>resistant</strong><strong>to antidiuretic hormone</strong> (ADH).</li>\n<li>This is either due to a receptor defect of vasopressin-2 receptor or a post-receptor defect in an ADH-sensitive water channel called aquaporin-2.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>SIADH (Option A):</strong> In patients with the syndrome of inappropriate secretion of ADH (SIADH), sodium levels are usually low, and patients will not present with polyuria.</p>\n<p><strong>Primary polydipsia (Option C): </strong>Primary polydipsia is a psychiatric disturbance characterised by the excessive intake of water. It is unusual at this age and is characterised by hyponatremia and diluted urine.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240408622a0c86-4675-4cd1-a79d-81029bb46613.jpg\">",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Psychiatric drugs are unlikely to have played a part in her condition</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Symptoms are unlikely to improve with desmopressin</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">The underlying condition is typically inherited in a dominant fashion</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">The symptoms are most likely due to excessive fluid intake driven by psychiatric factors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 46-year-old patient with bipolar disease presents with polyuria. On evaluation, the laboratory investigations were:<br>Na+ 142 mmol/L/l<br>Urea of 72 mg/dl; Creatinine of 1.58 mg/dL<br>Urine osmolality 250 mOsmol/l; Serum osmolality 297 mOsm/L.<br>Fasting plasma glucose is normal. <br>Which of the following statements best describes her condition?</span></p>",
      "unique_key": "DT1196110",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196110,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient likely has nephrogenic diabetes insipidus secondary to lithium use for bipolar disorder, a condition in which symptoms typically do not respond to desmopressin due to renal resistance to ADH.</p>\n<p><strong>Diabetes insipidus:</strong></p>\n<ul>\n<li>Diabetic insipidus patients present with polyuria (nocturnal enuresis, increased frequency) and are characterised by:\n<ul>\n<li><strong>Low urine osmolality</strong></li>\n<li><strong>High serum osmolality</strong></li>\n<li>Serum sodium concentration is almost always normal in DI, but results at the higher part of the reference range are more suggestive of DI.</li>\n</ul>\n</li>\n<li>DI can be either nephrogenic or central, which can be differentiated with a 2&mu;g desmopressin test.</li>\n</ul>\n<p><strong>Nephrogenic diabetes insipidus:</strong></p>\n<ul>\n<li>Either due to a receptor defect of <strong>vasopressin-2 receptor</strong> or a post-receptor defect in an ADH-sensitive water channel called <strong>aquaporin-2</strong></li>\n<li>As a result, the renal tubules do not respond to ADH even in the presence of ADH.</li>\n<li>Do not respond to 2&mu;g desmopressin test.</li>\n</ul>\n<p><strong>Central diabetes insipidus:</strong></p>\n<ul>\n<li>Central DI is characterised by deficiency or absence of ADH secretion from the posterior pituitary.</li>\n<li>Respond to 2&mu;g desmopressin test.</li>\n</ul>\n<p><strong>Drugs causing Nephrogenic diabetes insipidus:</strong></p>\n<ul>\n<li>Lithium</li>\n<li>Aminoglycosides</li>\n<li>Methoxyflurane</li>\n<li>Amphotericin B</li>\n<li>Demeclocycline</li>\n<li>Cisplatin</li>\n<li>Rifampin</li>\n<li>Foscarnet</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Psychiatric drugs are unlikely to have played a part in her condition (Option A): </strong>Mood stabilisers like lithium used in the treatment of bipolar disorders can induce nephrogenic diabetes insipidus. Lithium <strong>downregulates aquaporin 2 </strong>and decreases function of AVP, resulting in diabetes insipidus.</p>\n<p><strong>The underlying condition is typically inherited in a dominant fashion (Option C): </strong>Inherited form of Nephrogenic DI is most commonly due to V2 receptor mutation inherited by X-linked recessive pattern, whereas cranial diabetes insipidus is inherited with an autosomal-dominant or recessive pattern.</p>\n<p><strong>The symptoms are most likely due to excessive fluid intake driven by psychiatric factors (Option D): </strong>Polyuria due to excessive intake of water results in polydipsia, which is characterised by urine osmolality above 800 mOsm/kg and sodium levels below the normal range.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner's syndrome</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Bromocriptine therapy</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Sheehan's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient presenting with galactorrhoea, which of the following conditions is most likely to be the underlying cause?</span></p>",
      "unique_key": "DT1196146",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196146,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Hypothyroidism</strong> can present with galactorrhoea, due to raised prolactin levels.</p>\n<ul>\n<li>Hyperprolactinemia causes <strong>galactorrhoea</strong> and <strong>amenorrhoea</strong>, which may result from a prolactin-secreting pituitary tumour or hyperplasia.</li>\n<li><strong>Hypothyroidism </strong>is a cause of raised prolactin levels. Primary hypothyroidism can lead to elevated prolactin levels due to low T4 levels, resulting in an increase in TSH and thyroid-releasing hormone from the pituitary and hypothalamus, respectively.</li>\n<li>TRH has a stimulatory effect on the lactotrophs of the pituitary gland.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Turner's syndrome (Option A):</strong> Turner's syndrome (ovarian dysgenesis) causes primary amenorrhoea with poor development of the breast and is not associateone-thirdactorrhoea.</p>\n<p><strong>Bromocriptine therapy (Option B): </strong>Bromocriptine is a dopaminergic agent that has an inhibitory effect on prolactin and is frequently used to treat hyperprolactinemia.</p>\n<p><strong>Sheehan's syndrome (Option D):</strong> Sheehan's syndrome is a primary hypopituitarism due to necrosis of the pituitary gland caused by postpartum haemorrhage; it is characterised by failure of postpartum lactation due to hypoprolactinemia and failure to resume normal cyclic menstruation.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918ac09a6fc-480a-4ce5-bfe7-4444cba7f5b9.png\">",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple endocrine neoplasia</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary aldosteronism</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 39-year-old woman presents with high blood pressure, despite being on two anti-hypertensives. She reports her face becoming progressively rounder, worsening of acne and hirsutism. On evaluation, she had purple stretch marks on her abdomen with central obesity. Laboratory investigations revealed only impaired glucose tolerance. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196151",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196151,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's clinical presentation and findings are suggestive of Cushing syndrome.</p>\n<p><strong>Cushing's syndrome</strong></p>\n<ul>\n<li>Cushing's syndrome is related to excess cortisol production due either to excess ACTH secretion (from consequencestumor or an ectopic tumour) or to ACTH-independent adrenal production of cortisol.</li>\n<li>The term <strong>Cushing's disease</strong> refers specifically to Cushing's syndrome caused by a pituitary corticotrope adenoma.</li>\n<li><strong>Hypertension </strong>is present in more than 50% of patients, impaired glucose tolerance in 30%.</li>\n</ul>\n<p><strong>Major clinical signs and symptoms:</strong></p>\n<ul>\n<li>Round plethoric facial appearance</li>\n<li>Central obesity, <strong>buffalo hump</strong></li>\n<li>Thin, brittle skin</li>\n<li><strong>Purple abdominal striae</strong></li>\n<li>Acne, hirsuitism</li>\n<li>Proximal myopathy</li>\n<li>Hypertension, glucose intolerance</li>\n<li>Decreased libido, amenorrhea in women</li>\n</ul>\n<p><strong>Investigation:</strong></p>\n<p><strong>Screening tests:</strong></p>\n<ul>\n<li>24-h excretion rates of urine-free cortisol (increased 3 times above normal)</li>\n<li>Overnight dexamethasone suppression test (plasma cortisol &gt; 50 nmol/L at 8-9 am after 1mg dexamethasone at 11 pm)</li>\n<li>Late night salivary cortisol ( &gt; 5 nmol/L)</li>\n<li>Midnight plasma cortisol ( &gt;130 nmol/L)</li>\n</ul>\n<p><strong>Confirmatory test:</strong></p>\n<ul>\n<li><strong>Low dose Dexamethasone test </strong>(plasma cortisol &gt; 50 nmol/L after 0.5 mg dexametGenetic/syndromicys)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Pheochromocytoma (Option A):</strong> Phaeochromocytoma presents with episodic headaches, sweating and palpitation along with refractory hypertension.</p>\n<p><strong>Multiple endocrine neoplasia (Option B):</strong></p>\n<p><strong>Primary aldosteronism (Option C): </strong>Primary aldosteronism is characterised by resistant hypertension with hypokalemia and metabolic alkalosis.</p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">GH deficiency</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions can lead to short stature in children?</span></p>",
      "unique_key": "DT1196159",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The major causes for short stature in children include:</p>\n<ul>\n<li>Malnutrition</li>\n<li>Cbehaviourystemic illness (GI, renal, cardiac, rheumatologist)</li>\n<li>Endocrine (hypothyroidism, GH deficiency, Cushing syndrome, GH insensitivity)</li>\n<li>Genetic/syndromic cause</li>\n<li>Familial short stature</li>\n<li>Constitutional delay in growth</li>\n<li>Idiopathic short stature</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240412bdb36dec-2c3e-4300-a11a-8127e877b79f.jpg\">",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Lanreotide</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Octreotide acetate</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Pegvisomant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following acts by antagonising endogenous GH binding to its receptor?</span></p>",
      "unique_key": "DT1196179",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196179,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Pegvisomant is a <strong>GH analogue</strong> that antagonises endogenous GH action by blocking peripheral GH binding to its receptor.</li>\n<li>Consequently, serum IGF-I levels are suppressed, potentially reducing the deleterious effects of excess endogenous GH.</li>\n<li>Pegvisomant is administered by daily subcutaneous injection (10-30 mg) and normalises IGF-1 in ~70% of patients.</li>\n<li>GH levels, however, remain elevated as the drug does not target the pituitary adenoma.</li>\n<li>Side effects include reversible liver enzyme elevation, lipodystrophy, and injection site pain.</li>\n<li>Combined treatment with monthly Somatostatin receptor analogues and weekly or biweekly pegvisomant injections has been used effectively in resistant patients.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cabergoline (Option A):</strong> Cabergoline, a dopamine agonist, suppresses GH secretion, particularly in those with concomitant elevation of post-chiasmalin. Very high doses of cabergoline (0.5 mg/d) may achieve short-lived GH therapeutic efficacy. Combined treatment with octreotide and caber,goline may induce additive biochemical control compared with either drug alone.</p>\n<p><strong>Lanreotide (Option B), Octreotide acetate (Option C): </strong>Lanreotide and Octreotide are Somatostatin receptor 2 analogues that reduce both GH and IGF1 levels.</p>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Metyrapone</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitotane</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman diagnosed with Cushing's disease started on medical therapy. Which of the following drugs may be beneficial in managing her condition?</span></p>",
      "unique_key": "DT1196184",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>In Cushing's disease, <strong>steroidogenic inhibitors </strong>are used in combination with pituitary irradiation to block the adrenal effects of persistently high ACTH levels.</li>\n<li>The use of steroidogenic inhibitors has decreased the need for bilateral adrenalectomy.</li>\n</ul>\n<p><strong>Pharmacotherapy in Cushing's disease with steroidogenic inhibitors:</strong></p>\n<ul>\n<li><strong>Pasireotide,</strong> a somatostatin receptor ligand with high affinity for SST5 &gt; SST2 somatostatin receptor subtypes, controls hypercortisolemia in patients with ACTH-secreting pituitary tumours when surgery is not an option or has not been successful.</li>\n<li><strong>Ketoconazole</strong>, an imidazole derivative antimycotic agent, inhibits several P450 enzymes and effectively lowers cortisol in most patients with Cushing's disease.</li>\n<li><strong>Mifepristone,</strong> a glucocorticoid receptor antagonist, blocks peripheral cortisol action and is approved to treat hyperglycemia in Cushing's disease.</li>\n<li><strong>Metyrapone</strong> inhibits 11&beta;-hydroxylase activity and normalises plasma cortisol in up to 75% of patients.</li>\n<li><strong>Mitotane</strong> suppresses cortisol hypersecretion by inhibiting 11&beta;-hydroxylase and cholesterol sidechain cleavage enzymes and by destroying adrenocortical cells.</li>\n</ul>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral inferior visual field deficits</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral superior visual field deficits</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Bitemporal hemianopia</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Central scotomas bilaterally</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male with a history of pituitary adenoma presents with defective vision.  Imaging studies revealed adenoma extending superiorly and compressing optic chiasm. Which of the following visual field deficits is most likely present?</span></p>",
      "unique_key": "DT1196188",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196188,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Compression of the central optic chiasm by a pituitary adenoma disrupts crossing nasal retinal fibres, leading to bitemporal hemianopia.</p>\n<ul>\n<li>Optic chiasma lies 10mm above the pituitary gland.</li>\n<li>Pituitary enlarges, predominantly superiorly and anteriorly, which compresses optic chiasma, resulting in <strong>bitemporal hemianopia.</strong></li>\n<li>It results from compression of <strong>nasal retinal fibres</strong>, which cross at the optic chiasm.</li>\n<li>Bitemporal hemianopia is the <strong>commonest visual field defect</strong> associated with pituitary adenoma.</li>\n<li><strong>Homonymous hemianopia </strong>may occur if the lesion compresses the post-chiasmal optic tract. (adenoma enlarges posteriorly)</li>\n<li><strong>Monocular temporal field loss </strong>can result from pre-chiasmal compression, where adenoma enlarges anteriorly to compress the optic nerve.</li>\n<li>If adenoma extends laterally into cavernous sinus, it may involve cranial nerves III, IV, and VI, leading to ptosis, diplopia, and extraocular muscle palsy.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918c0e30d5d-7f1f-4e2f-a48e-5afaafa39a5f.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Bilateral inferior field defects (Option A): </strong>These defects are uncommon in pituitary adenomas, as this pattern suggests compression of optic chiasma from above, not below.</p>\n<p><strong>Bilateral superior visual field deficits (Option B): </strong>Superior or bitemporal field defects can occur if adenomas compress the optic chiasma inferiorly.</p>\n<p><strong>Central scotomas bilaterally (Option D): </strong>Central scotomas result from optic nerve injuries or macular damage, and bilateral central scotomas are seen with conditions like optic neuritis.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040899e579f2-c7d7-465e-94cd-036bb9685f93.jpg\">",
      "correct_choice_id": 253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal Cell Cancer</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung Cancer</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Colon cancer</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell cancer of skin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male was recently diagnosed with an endocrine disorder caused by excess secretion from somatotrope cells of the anterior pituitary. Which of the following malignancies may occur in this patient due to the underlying condition?</span></p>",
      "unique_key": "DT1196191",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Somatotrope cells of the anterior pituitary secrete growth hormone; its hypersecretion in post-pubertal individuals leads to acromegaly, which is associated with an increased risk of developing <strong>colon cancer.</strong></p>\n<p><strong>Impact of excess GH:</strong></p>\n<ul>\n<li>The most significant clinical impact of GH excess occurs on the <strong>cardiovascular system.</strong></li>\n<li>Cardiomyopathy with arrhythmias, LVH, decreased diastolic function, and hypertension ultimately occur in most patients if untreated.</li>\n<li>Upper airway obstruction with sleep apnea occurs in &gt;60% of patients.</li>\n<li>Diabetes mellitus develops in 25% of patients with acromegaly, and most patients are intolerant of a glucose load (as GH counteracts the action of insulin).</li>\n<li>Acromegaly is associated with an increased risk of <strong>colon polyps a</strong>nd mortality from colonic malignancy; polyps are diagnosed in up to one-third of patients.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918618d4334-9e2e-4f72-9987-24d4da88f87f.png\">",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid-stimulating hormone</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Leutenizing hormone</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocorticotrophic hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormone deficiencies occurs first in case of hypopituitarism due to compression by a mass?</span></p>",
      "unique_key": "DT1196195",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Trophic hormone failure associated with pituitary compression or destruction usually occurs sequentially: growth hormone &gt; follicle-stimulating hormone &gt; luteinizing hormone &gt; thyroid-stimulating hormone &gt; adrenocorticotropic hormone.</li>\n<li>During childhood, <strong>growth retardation</strong> is often the presenting feature, and in adults, <strong>hypogonadism </strong>is the earliest symptom.</li>\n<li><strong>GH deficiency</strong> is also the most common hormone deficiency associated with radiation to the sellar region.</li>\n</ul>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocorticotrophic hormone</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid-stimulating hormone</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Leutenizing hormone</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Metyrapone test is useful for the diagnosis of which hormonal deficiency?</span></p>",
      "unique_key": "DT1196199",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196199,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The metyrapone test is used for hypothalamic evaluation of the HPA axis in adrenal insufficiency; <strong>adrenocorticotrophic hormone </strong>responsiveness to adrenal blockade with metyrapone is assessed.</p>\n<p><strong>Metyrapone test:</strong></p>\n<ul>\n<li>Metyrapone is an 11 beta hydroxylase inhibitor; it inhibits the conversion of deoxycortisol to cortisol.</li>\n<li>In normal individuals, reduced cortisol levels will lead to a lack of negative feedback to the anterior pituitary, resulting in a compensatory rise of ACTH.; This response is lacking in patients with ACTH deficiency (hypopituitarism).</li>\n</ul>\n<p><strong>The gold standard investigation for:</strong></p>\n<ul>\n<li>Secondary adrenal insufficiency - Insulin tolerance test</li>\n<li>Primary adrenal insufficiency - Synacthen / cosynstropin stimulation test.</li>\n</ul>\n<p><strong>Tests for pituitary insufficiency:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240408a613dd9c-f15f-4cfa-918f-3c77cdfe6da5.jpg\">",
      "correct_choice_id": 281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}